Devyser Diagnostics AB Namn-Aktier o.N.
- BID
5.58
- ASK
5.67
- 538 Units353 Units
- 07/21, 16:34:05 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
50.43%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.05 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 5.58 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:31:32 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 5.72 | 5.47 |
| PREV. DAY'S PRICE | 5.72 | (07/20) |
| CHANGE DAY BEFORE | -0.14 | -2.45 % |
| 52 WEEK HIGH / LOW | 14.2 (09/23) | 5.23 (07/07) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.29 | -0.33 | -0.05 | 0.05 | 0.19 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | 114.55 | 29.72 |
PRICE - BOOK RATIO | 3.32 | 5.62 | 5.37 | - | - |
PRICE - SALES RATIO | 7.51 | 8.96 | 7.56 | - | - |
PRICE - CASH FLOW RATIO | - | - | 231.08 | - | - |
Master Data
| WKN | A3C811 |
| ISIN | SE0016588867 |
| SYMBOL | OL0 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | DEVYSER DIAGNOSTICS AB |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 4.19 % | -26.57 % | -29.30 % | -40.79 % | -50.43 % | -8.92 % | - | -44.03 % |
| HIGH | 5.97 | 7.88 | 9.25 | 10.22 | 14.20 | 14.20 | - | 10.56 |
| LOW | 5.36 | 5.23 | 5.23 | 5.23 | 5.23 | 4.82 | - | 5.23 |
Dividende
pro Aktie
DEVYSER DIAGNOSTICS AB does not deliver dividend information
Company profile
Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. Its products are used for complex DNA testing in the areas of hereditary diseases, oncology and post-transplantation monitoring. The firm's products are also used in treating cancer patients and in follow-up transplant patients. The company was founded by Anders Hedrum, Ulf Axel Klangby and Dan Hauzenberger in 2004 and is headquartered in Hägersten, Sweden.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.